Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?Christoph Röllig, Martin Bornhäuser, Stefan W. Krause et al.|Blood|2020Cited by 137
NFATc1 as a therapeutic target in FLT3-ITD-positive AMLStephan Metzelder, Andreas Burchert, Christian Michel et al.|Leukemia|2015Cited by 52
Outcome of non-mold effective anti-fungal prophylaxis in patients at high-risk for invasive fungal infections after allogenic stem cell transplantationDeborah Christen, Andreas Burchert, Kristina Sohlbach et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 3
Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemiaChristian Michel, Andreas Burchert, Elisabeth Mack et al.|Haematologica|2019Cited by 0